- /
- Supported exchanges
- / US
- / EKTAF.PINK
Elekta AB (publ) (EKTAF PINK) stock market data APIs
Elekta AB (publ) Financial Data Overview
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as well as quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit, a gamma knife system; and Leksell GammaPlan, a treatment planning and management software, as well as Elekta ONE, an oncology software suite. In addition, the company offers brachytherapy products, including Elekta Studio, an image-guided brachytherapy solution; ImagingRing for dynamic imaging; Oncentra Brachy, a smart tool that facilitates repetitive tasks; Elekta Xoft Axxent and electronic brachytherapy systems; Elekta Geneva, an applicator for cervical cancer patients; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Venezia applicator that enables the oncologist to treat locally advanced cervical cancer. Further, it provides Leksell Vantage Stereotactic System, a neurosurgery product; Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. Additionally, the company offers Elekta Care support services; Elekta Care 360, which provides a range of clinical and professional services; Elekta Care Learning that offers in-person and digital training courses on radiotherapy; Elekta Care Community, a self-help center; Elekta Partner Community, an online self-service portal; and Elekta Intellimax for predictive maintenance. Elekta AB (publ) was incorporated in 1972 and is headquartered in Stockholm, Sweden.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Elekta AB (publ) data using free add-ons & libraries
Get Elekta AB (publ) Fundamental Data
Elekta AB (publ) Fundamental data includes:
- Net Revenue: 17 567 M
- EBITDA: 1 957 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-26
- EPS/Forecast: 0.59
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Elekta AB (publ) News
New
Elekta showcases Evo, its AI-powered, online adaptive CT-Linac at the Association of Medical Physicists of India - National Congress 2025 (AMPICON) in Guwahati
Evo features high-definition image quality and online adaptive radiotherapy capabilities for treating cancer GUWAHATI, India, Dec. 5, 2025 /PRNewswire/ -- Elekta announced the introduction of its lat...
3 European Stocks That May Be Priced Below Their Estimated Value In December 2025
As European markets experience a positive momentum, with the STOXX Europe 600 Index and major country-specific indexes seeing gains, investors are increasingly focused on identifying stocks that may b...
European Equity Bargains Valued Below Estimated Worth In December 2025
As European markets experience a notable upswing, with indices like the STOXX Europe 600 and Germany's DAX showing significant gains, investors are increasingly attentive to opportunities within the r...
European Equity Opportunities That May Be Undervalued In November 2025
As European markets grapple with concerns over inflated AI stock valuations and the impact of U.S. interest rate expectations, the pan-European STOXX Europe 600 Index has seen a decline, reflecting br...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.